HomeCompareMLCT vs EPRT

MLCT vs EPRT: Dividend Comparison 2026

MLCT yields 1025.64% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLCT wins by $23506543.46M in total portfolio value
10 years
MLCT
MLCT
● Live price
1025.64%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23506543.53M
Annual income
$19,723,609,349,823.79
Full MLCT calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — MLCT vs EPRT

📍 MLCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLCTEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLCT + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLCT pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLCT
Annual income on $10K today (after 15% tax)
$87,179.49/yr
After 10yr DRIP, annual income (after tax)
$16,765,067,947,350.22/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, MLCT beats the other by $16,765,067,936,435.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLCT + EPRT for your $10,000?

MLCT: 50%EPRT: 50%
100% EPRT50/50100% MLCT
Portfolio after 10yr
$11753271.80M
Annual income
$9,861,804,681,332.26/yr
Blended yield
83.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MLCT
No analyst data
Altman Z
-1.8
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLCT buys
0
EPRT buys
0
No recent congressional trades found for MLCT or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLCTEPRT
Forward yield1025.64%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$23506543.53M$63.4K
Annual income after 10y$19,723,609,349,823.79$12,840.73
Total dividends collected$23218513.75M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MLCT vs EPRT ($10,000, DRIP)

YearMLCT PortfolioMLCT Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$113,264$102,564.10$11,205$505.18+$102.1KMLCT
2$1,206,878$1,085,685.14$12,672$682.46+$1.19MMLCT
3$12,102,987$10,811,628.23$14,490$930.48+$12.09MMLCT
4$114,279,868$101,329,670.98$16,786$1,282.69+$114.26MMLCT
5$1,016,469,856$894,190,397.43$19,753$1,791.56+$1016.45MMLCT
6$8,520,740,273$7,433,117,527.67$23,677$2,541.64+$8520.72MMLCT
7$67,350,310,269$58,233,118,176.66$29,008$3,672.99+$67350.28MMLCT
8$502,243,173,894$430,178,341,906.41$36,463$5,425.08+$502243.14MMLCT
9$3,535,452,502,858$2,998,052,306,790.74$47,238$8,221.57+$3535452.46MMLCT
10$23,506,543,527,881$19,723,609,349,823.79$63,385$12,840.73+$23506543.46MMLCT

MLCT vs EPRT: Complete Analysis 2026

MLCTStock

Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.

Full MLCT Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MLCT vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLCT vs SCHDMLCT vs JEPIMLCT vs OMLCT vs KOMLCT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.